China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Valproic Acid Serum Concentration on Survival in Patients with Glioma-Associated Epilepsy: A Single-Arm, Prospective Cohort Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131682
Registration Time: 2026/09/05
Type: Observational study
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338323
Published by HT Digital Content Services with permission from Health Daily Digest....